Iomeron (Iomeprol)

Iomeron (iomeprol) is an iodinated contrast agent used to improve radiographic visualization of vascular and joint structures.

• Angiography: Provides high‑contrast images of blood vessels to support diagnosis and interventional procedures.
• Arthrography: Enhances joint space visualization, facilitating assessment of cartilage, ligaments, and intra‑articular pathology.
• CT imaging: Increases tissue attenuation differences, allowing detailed cross‑sectional images of organs and vessels.
• Vascular imaging: Improves delineation of arterial and venous anatomy during fluoroscopic and CT angiographic studies.

• Iomeprol is a non‑ionic, low‑osmolality iodinated contrast medium. Each molecule contains multiple iodine atoms that strongly absorb X‑ray photons, raising the radiodensity of the extracellular fluid and tissues into which it distributes. After intra‑arterial, intra‑articular, or intravenous administration, the agent rapidly equilibrates in the vascular and interstitial compartments, creating a pronounced contrast between blood vessels, organs, and surrounding structures on CT or fluoroscopic imaging.

Iomeron may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Warm sensation or flushing: transient feeling of heat during injection.
• Nausea or vomiting: mild gastrointestinal upset that usually resolves quickly.
• Urticaria or mild skin rash: temporary itching or hives.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response that can be life‑threatening.
• Acute renal impairment: sudden decrease in kidney function, particularly in patients with pre‑existing renal disease.
• Severe hypotension or shock: marked drop in blood pressure requiring medical intervention.

Prior to administering Iomeron, several precautionary measures should be observed to minimize risk.

• Assess renal function: evaluate serum creatinine and eGFR before use.
• Review allergy history: check for prior reactions to iodinated contrast or iodine‑containing substances.
• Use lowest effective dose: tailor volume to the specific imaging study.
• Monitor vital signs: observe blood pressure, heart rate, and oxygen saturation during and after injection.
• Avoid in known iodine hypersensitivity: contraindicated in patients with documented severe allergy to iodinated agents.
• Store at ambient temperature: keep in original container, protect from moisture and direct light.

Iomeron can interact with certain medications, affecting safety or efficacy.

Major Interactions (Avoid)

• Concurrent use of other iodinated contrast agents: cumulative iodine load may increase risk of toxicity.
• Co‑administration with nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): may exacerbate renal impairment.

Moderate Interactions (Monitor Closely)

• Diuretics: may alter renal clearance of the contrast medium, requiring hydration monitoring.
• Metformin: in patients with reduced kidney function, temporary discontinuation is advised to prevent lactic acidosis.
• Thyroid medications: excess iodine can affect thyroid hormone synthesis, necessitating thyroid function monitoring.